Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · IEX Real-Time Price · USD
56.09
-0.84 (-1.48%)
At close: Mar 28, 2024, 4:00 PM
56.00
-0.09 (-0.16%)
After-hours: Mar 28, 2024, 6:46 PM EDT

Legend Biotech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
285.14117.0168.837559.9849.13
Revenue Growth (YoY)
143.70%70.00%-8.23%25.04%22.08%-
Cost of Revenue
144.2165.360000
Gross Profit
140.9351.6468.837559.9849.13
Selling, General & Admin
200.93174.05149.572.7132.373.93
Research & Development
382.22335.65313.35232.16161.9460.64
Other Operating Expenses
-58.13-12.05-3.06-6.12-7.46-13.9
Operating Expenses
525.02497.65459.79298.75186.8650.67
Operating Income
-384.09-446.01-390.96-223.75-126.88-1.53
Interest Expense / Income
21.7910.80.94.210.220.08
Other Expense / Income
114.23-11.0815.3380.330.220
Pretax Income
-520.12-445.72-407.2-308.29-127.32-1.62
Income Tax
-1.860.63-3.61-41.91-25.731.17
Net Income
-518.25-446.35-403.58-266.37-101.59-2.78
Shares Outstanding (Basic)
352318282236200-
Shares Outstanding (Diluted)
352318282236200-
Shares Change
10.71%12.91%19.21%18.15%--
EPS (Basic)
-2.94-2.80-2.86-2.26-1.02-0.02
EPS (Diluted)
-2.94-2.80-2.86-2.26-1.02-0.02
Free Cash Flow
-460.39-252.24-199.53-259.54-103.13285.02
Free Cash Flow Per Share
-2.62-1.59-1.42-2.20-1.03-
Gross Margin
49.42%44.14%100.00%100.00%100.00%100.00%
Operating Margin
-134.70%-381.18%-568.05%-298.33%-211.53%-3.12%
Profit Margin
-181.75%-381.48%-586.38%-355.16%-169.37%-5.67%
Free Cash Flow Margin
-161.46%-215.58%-289.91%-346.06%-171.95%580.10%
EBITDA
-477.87-416.54-392.38-294.14-121.830.13
EBITDA Margin
-167.59%-356.00%-570.10%-392.19%-203.12%0.27%
Depreciation & Amortization
20.4518.3913.929.935.261.67
EBIT
-498.32-434.93-406.3-304.08-127.1-1.53
EBIT Margin
-174.76%-371.72%-590.32%-405.43%-211.90%-3.12%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).